TNGX EBITDA Growth
Tango Therapeutics Inc · EBITDA Growth
TNGX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported14.73%period ending
TNGX TTM EBITDA YoY % (-10.96% → 14.73%)
Year-over-year change
High-resolution chart · PNG
TNGX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 14.7259% | |
| 18.8529% | |
| 22.1686% | |
| 18.8147% | |
| -25.5436% | |
| -18.8494% | |
| -28.6305% | |
| -23.7433% | |
| -8.8846% | |
| 0.0229% | |
| 6.8714% | |
| 2.1597% | |
| -15.6965% | |
| -55.5144% | |
| -86.716% | |
| -126.014% | |
| -75.8827% | |
| -26.7068% | |
| -10.9628% |